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1. Introduction. I / 
This space bioprocessing coritract e f f ~ r t  was comprised of four I 
general objectives. These were; 1) the evaluation of current separation 
1 processes; 2)  the  ident i f ica t ion of problem relevant t o  the separation 
of important biologicals ; 3) the ident i f ica t ion of graund-based assay 
methods neeJed fo r  pre- and post f l ight  ard .ys is  of space bioprocessing 
separation technology; and b )  the establishment of methods t o  determine 
the efficiency of space bioprocessing separation procedures. 
Several biological disciplines may have been appropriate a s  an 
avenue fo r  pursuit  of these objectives. However immunology was deemed 
advantageous f o r  this purpose because of tbe divers i ty  of cells and ce l l  
products involved and the extensive in te res t  beinq given t o  t h e i r  sep- 
aration. Upon recognition of a ce l lu lar  o r  molecular agent a s  foreign 
t o  the body, the  immune system beccnes activated t o  produce c e l l s  whose 
function i s  t o  destroy t ha t  agent and c e l l  products whose function i s  
t o  inactivate the agent and a s s i s t  in its destruction. Long a f t e r  the 
agent is  removed from the body, some c e l l s  remain in a s t a t e  of r e a d i ~ e s s  
t o  continue these destructive actions speci f ica l ly  against t h a t  agent 
should further exposure t o  it occur. T h i s  is the  bas i s  of acquired im- 
m i t y  t o  disease. 
The a b i l i t y  of selected non-human m a w s  t o  produce imnune agents 
suitable fo r  humao diap.ostic em! therapeutic use can be u t i l i zed  if ths 
srecific e n t i t i e s  involvod are obtainable i n  su f f i c ien t  pur i ty  and quan- 
tity. T h i s  commercial productive capabil i ty is limited by the f ac t  t ha t  
sought. For t h i s  reason, advances i n  separation technolow bave enjoyed 
a s t r o r i  i n t e r e s t  from the innunology community. The potential  contri- 
butions of space bioprocossing t o  separation technology would seem a t  
-. 
l e a s t  equally appropriate i n  t h i s  respect. 
Several separation methods were u t i l i z e d  i n  tho contract ob j ec t i ve s  
pertaining t o  the evaluation of current separation procedures. Density 
gradient centrifugaticn, f i l t r a t i on ,  adsorption chromatography, electro- 
phoresis, and l a se r  activatzd c e l l  sort ing were studied by various ap- 
proaches t o  achieve 8 perspective of current separation technology i n  
re la t ion t o  the potential  advantages of space bioprocessing. W i t h  some 
methods, actual  trirls were performed using i ~ m e - r e l a t e d  biologicals 
and with other methods, a tt.eoreticc=l analysls of the  separation capa- 
b i l i t - i s a  vqs p ~ r f o m s d  w i n g  l i t e r a tu r e  sources as en imprt.ant infor- 
aation base. 
The objective t o  ident i fy  problems relevant t o  the separation of 
jhpor tant  biologicals was very c o ~ p a t i b l e  w i t h  the need fo r  improved 
separation capabil i t ies f o r  imnrme-related c e l l s  and c e l l  products. 
Therefore the separation of several c e l l  types and products was studied 
usinq current techniques as a mans of di rect ly  observing these problems. 
Lynphocytes, tumor ce l l s ,  and rheumatoid factors  were among these bio- 
Iceicals. 
A t h i r d  objective, t ha t  of identifying ground-based assay metbods 
needed for pre- u d  postfl ight  analytical  support of space bioprocesainq 
k. ct~nclogy, was apprcached through the study of specific Fmmunological 
applications of genaralized assay procedures, Included i n  these proce- 
V f - r P  i m - ~ i n ~ d  jf~L*.SICII, r:.<r~?,i-::!.2it:.1 ?.II:! gt&;:.inr cethods. As537s 
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f o r  a variety of c e l l  types and products were encompassed by the  range 
of applications of these procedures. 
A fourth objective t o  establish methods fo r  detenrdning the  e f f i -  
.- 
ciency of space bioprocessing separations was approached by considera- 
t i o n  of the requirements fo r  earth-based applications of isola ted bio- 
logicals. The potential  quantity 3nd quali ty of product were considered 
with respect t o  t ha t  required fo r  a Jus t i f ied  benef i t  t o  earth-based 
operations. 
The approaches used t o  pursue these objectives w i l l  be presented 
I n  fur ther  d e t a i l  i n  subsequent sections. The r e su l t s  of t h i s  study 
will then be presented a f t e r  which recommendations fo r  fur ther  e f fo r t s  
compatible w i t h  the goals of space bioprocessing will be given. An 
expenditure summary wil l  then follow. The l a s t  two sections w i l l  deal 
respectively with a general sunrmation of the  contract e f fo r t  and the 
conclusions result ing therefrom. 
I 
2. Evaluation of Current Separation Processes. 
I n  order t o  assess tbe potential  advantages of space bioprocessing 
technology for  separation applications, a preview and prelimirary eval- 
uation of several ground-based separation methods were conducted. The 
requirements f o r  obtaining adequate ground-based control data and the 
possible advantages of complimentary separation procedures i n  the 
Shutt le Spscelzb environment were considerod in t h i s  aspect of the con- 
t r a c t  ef for t .  Included in the separation methods considered were density 
gradient centrifugation, electrophoresis, adsorption chromatography, 
0'1 +-attor,, ad laser activated ze l l  scrtir.:: ,Vc?eXS. - -- .. 
a. Density Oradient Centrifugation. 
Because of the ve r sa t i l i t y  of density gradient centrifugation as 
evidenced by the wide range of research areas i n  which it is currently 
used, t h i s  method was examimd i n  de ta i l  a s  a c e l l  separation technique. 
The increased gravitat ional  force applied t o  t h e  c e l l s  can be controlled 
by the centrifuge speed and the counteractive buoyancy force on the c e l l s  
can be varied by the specific gravity of the  gradient medium. Discon- 
tirn~ous and continuous gradient columns can be used t o  f ie ld  a f i n i t e  or 
theoretically i n f i n i t e  number of fractions respectively. Further re- 
finements of separation capabil i ty may be achieved by optimizing the 
centrifugation period. Temperature must be controlled so tha t  heat dam- 
age t o  l iv ing  ce l l s  i s  negligible. In sp i te  of the extensive range of 
controllable factors  which car1 influence the quality of separation, c e l l s  
are still separated on the basis  of density. The ra ther  limited range of 
c e l l  densities, part icularly between c e l l  types of a common parentage, 
is responsible fo r  a res t r ic ted appl icabi l i ty  of t h i s  separation method. 
Also there must be a suff ic ient  correlat ion between c e l l  function and 
density fo r  the technique t o  be p rac t ic r l  i n  isola t ing specific c e l l s  
w i t h  functional homogeneity. Such correlation is  not present i n  maw 
c e l l  l ines .  
Density gradient centrflugation may be enhanced by the induction of 
a l tera t ions  in c e l l  density on a pre-selected basis. Density modifica- 
t ion  techniques such as  antibody complex formation, rosset te  formation, 
and heavy par t ic le  ingestion, a re  subject t o  disadvantages of ins tabi l i ty ,  
: ; n - ,  : . - , .   7 - -.. . .  . , a  : 7 ,  The larce 
gravitat ionai  forces exerted on these ce l l s  may also be contributory t o  
- ,&:., . -*..-.-. -. " -  _ A , .  . .  - ..---I- - 
ce l l  damage and a f f ec t  subsequent assay procadures such as cytotoxicity 
measurement and v i ab i l i t y  determination, Thorefore ddnsity gradient 
centrifugation methods were found t o  have a rather limited u t i l i t y .  
be  Electrophoresis. 
Electrophoresis i s  applicable t o  the separation of c e l l s  and c e l l  
products. Separation i s  based upon several determirants. Size, mass, 
and net  aurface charge are  the primary determinants, The combined ef-  
f e c t  of these determinants and i ~ e i r  correlat ion t o  function are such 
that  functional homogeneity of the  resultant  fractions was more pro- 
mising than u i t h  many other separation nethods, 
Electrophoresis technology has been developed in to  a variety of 
systems, Modifications of bclf f er , field strength, flow ra te ,  sample 
introduction, supporting medium, geon:r~t,ry, acd spa t ia l  orieritation have 
been used t o  improve the  separation capabi l i t ies  of t h i s  basic method. 
In  the earljr electrophoretic systens, gravity was not considered much of 
a l imiting factor f o r  obtaining puri ty or quantity of product. As 
electrophoresis technology progressed, the e f fec t s  of gravity In l i m -  
i t i n g  the separation capabi l i t ies  becane more significant .  
Two ,major influences of gravity upon electrophcretic systems are  
sedimentation arul convection. Sedimentation of par t i c les  impedes t he i r  
mobility and may also  promote a clumping effect ,  Convection currents 
ar ise  from heat produced by the e l ec t r i c  f i e l d  current In a one-gravity 
ermirom.ent. A horitontally rota t ing electrophoresis system has been 
developed as om means of reducing these gravitat ional  effects.  A t  bes t  
. . ?  , . . -..- . . ,. ,;r..* :.- t ~ n :  c.;? OPLY ?IF-:. : -  - ;.ze t h e  e:l'r;ct~ - :' ~ s v i t y  and di:- 
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tribute them uniformly throughout the column but t h i s  can not be con- 
sidered the  equivalent of a near-cero gravity environment. In addition 
these rota t ional  forms of electrophoresis ~ystema have been burdened 
u i th  t h e i r  own unique dis tor t ing influences. 
Other variations of the electrophoretic basia of separation have 
resulted i n  a divers i ty  of systems. Some dosigns are directed toward a 
high qual i ty  of pur i ty  i n  separ-ation ard others toward a high volume of 
sample throughput. One approacb, continuous flow electrophoresis, seems 
t o  incorporate both of these ad van tag;:^. It is t h i s  approach which 
seems most promising as a space bioprocessing separation method becauso 
of t b i a  dual u t i l i t y ,  
c. Adsorption Chronato~ranhy. 
-.- 
Adsorption chro.mtographg is sin;iIcw t o  ulectropboresis i n  that 
separation occurs as  a suspending medium is passed through a matrix. 
However with adsorption chrorr,atographr, the matrix par t ic les  are  coated 
I w i t h  a molecular species haring a selective a f f i n i t y  for  a par t icular  
solute. T h i s  a f f in i ty  i s  based prfnari ly on chc;nical structure and is 
only as specific as the se lect iv i ty  of the  binding agent. The use of 
immune-reactive conpounds as birding agents renders t h i s  s y s t e m  of some 
potential  valua i n  i sola t ing antibodies and antigens. It i s  also pos- 
s i b l e  t ha t  i f  suff ic ient ly  selective antibodies t o  functionally homog- 
enous c e l l  populations could be obtainad, a f f i n i t y  chromatography would 
have 8 potential  capability fo r  separating c e l l  typos as well  as c e l l  
products. 
A re la t ively  large volume of sample can be handled by t h i s  method 
and the binding agnnt can be recavorad for reuse. Gravity is  not con- 
sidered a major interfering factor so t h a t  tbore is  no apparent advan- 
tage of using t h i s  systex fo r  i n f l i i f h t  space bioprocessing. However it 
my be of benefi t  i n  pre- and postfl ight  procedures. 
d. Fil t ra t ioc .  
Tile f i l t r a t i o n  methods exa.nj.nsd consisted of u l t r a f i l t r a t i o n  and 
gel f i l t r a t ion .  Ul t ra f i l t r a t ion  is  a separation technique applicable t o  
nucromolccular separation; an3 i s  based upon 62ze alone. For t h i s  reason, 
it has a very limited value i n  i s o l a t i n g  specifical1.y reactive i r a m o -  
globdins  i n  a s ~ l t a b l y  pure ~trit.-. It does  seen useful fo r  preliminary 
preparative procedur~s ho!:;.rer. 
Gel f i l t r a t i o n  u t i l i z e s  a corbinxtion of dc"tcr;nina3ts, size and 
diffusabilfVj, t o  separate ~nolec.~!.i!.ar entities. The basis of gel f i l t r a -  
t ion  is tha t  the  l l ou  of smaller molecules t b r m g h  a column of e . 1  beads 
under proper conditions, can be retarded by diff rs ion of these smaller 
molecules through the ge l  n a t r k .  Because larger molecules are not able 
t o  enter  the matrix pores, they flo;* t<hrougn the column a t  r faster  rate. 
Although s ize  and d i f f u s ~ b i l i t y  in t h o  g e l  medium a t e  the primary dster-  
minanta, ad juutaents of p3, gel dens it^, homogeneity of column packing, 
and temperature can be optimized f o r  part icular  separations. The rela- 
tiw insensi t iv i ty  of g e l  f i l t r a t i o n  for  biochemically similar  but func- 
t ional ly  d i s t inc t  compounds is suff ic ient  t o  severely r o s t r i c t  its use- 
F '  . !  \,,- , . I  
. -  . . . , .  , :.-.:I :.2 COT; :o:-rfG a c.?n2':?:tt: f :  :- sreparati-re se.3- 
ir .A ,, ,.: -. ..., >lii, . .; l ; Y - ~ > i '  t o  :r,o; ; cunsiLlve an! YL!;,,, ;;icated tecnniqut:.~. 
Laser Astivated Cell Sorting. 
-- 
The laser  activated ce l l  sorting method was investigated because it 
i s  conaidered by many as the most recent major advancement in  separation 
technology. It can be used for  separation of ce l l s  or  particles of 
macronolecular size. The ce l l s  or particles are coated u i t b  a fluorea- 
cent material and individually passed through a narrow channel. Fluo- 
rescence occurs when the ce l l  or particle is struck bp a laser  beam 
directed across the channel. Tho fluorescence is detected and measured. 
The c e l l  or  partic3.e type is  categorized by the amount of fluorescence 
measured. T h i s  information is then used by a computerized control system 
t o  detenrrlne the deflection of the flow path t o  preselected receptacles. 
Several advantage are ?resent i n  t h i s  method of separation. A 
separotiorr of ce l l s  or  particles on an individual basi . is possible and 
a very largo throughput can be handled automatically. A large amount 
of flexibility is possible by reprograming the computerized controller 
/ processor. The selectivity of t h i s  system seem limited by the number 
of fluorescent coatings available. Hawevor there is promise of an in- 
creased number of coatines as the potential applications of t h i s  sjstem 
are developed. 
The major disadvantage of t h i s  system is economics. The current 
price is  approximately $116,000. The sophistication of technical per- 
clonnel required for  i t s  operation is also an economic drawback. 
However the quality of separation appears very promising. Although 
its use as  an inf l ight  procedure does not seem Justified, it would be 
verp useful i n  preparative aeparat,ian of ce l l  or nolccular .~l.xturoa p r ? v  
t o  spece bioprocossfnF: separation  leth hods within the  Shuttle Sprcelab 
env i romnt ,  
3, Identification of Problenls Relev,mt. t o  the Separation of Inportant 
- 
B i o l o ~ i  cals. 
1,aboratory exercises i n  representative mm~anologic applications of 
current s e p r a ~ i o n  technology were performed *Lo provide first-hand exper- 
ience w i t h  research problems t ha t  mny bonefit from space bioprocessixq 
separatioi~ procedures, These applications w i l l  be discussed with em- 
phasis of t h : ? i r  relermce t o  a>zce bioprocessing, Three apecific sepa- 
r a t i o n  i ; p p l i ~ i ~ i . i ~ n s  ?:ere studied ; i sola t ion of tumor ce l l s ,  separation 
of lymphocy%c c u b g ~ o ~ ; ? ~ ,  and i sola t ion of rheumatoid factors. 
T..zor c e l l s  pr@su?n-t a u n i q ~ e  challenge t o  the  surveillance function 
of t h l j  ixi.?lr;.~: systaz. I n  one respect, they may not be easily recogniz- 
able as fo re ign  to tho body because they ariae from endogenous precursors. 
I n  a ~ o t h e i  .)s?ect, the i r  usually degenerative nature renders them physi- 
ologically forci,gn t o  ths body, 
  his endogenous parentage of tumor ce l l s  
i s  thought res9onsiblc for a wakened antigenicity of these ce l l s ,  T h i s  
dccreaaed antigenicity and the interspersion of normal ce l l s  witbin 
tumorous t i s sne  were considered jus t i f ica t ion t o  attempt the i sola t ion 
of tumor c6 l l s  from t~unorous t i ssue f o r  possible c la r i f i ca t ion  of the  
inmano mc)ta,?icns in o?cration, 
The method of c e l l  separation considered I n i t i a l l y  was ,entrifu- 
%--*.4 n- x4+h4- 3 8 n - * - + ,  r?.n3lo:t >f ~ f c r j ~ l - ~ . I : , ~ n c ; . ~ ~  ( ~ ' c ~ p ~ , ~ ,  ;963; ?'..?a- 
twenty rainutes i n  a solution of 10  Kl.. of 9.0 % Fico'll and 2.75 nil. of 
9 $ sodium bypaque removed erythrocytes from the  suspension but had 
l i t t l e  additional merit. 
.- 
Therefore a second approzch of density gradient centrifugation was 
attempted using discontinuous albumin solutions as t h e  gradient colunn 
(~ickie, 1975). The c;;lln!.t;J. m t u e  of albuqin i n  solu?.ion is a re tar-  
dant t o  the mixing of di f ferent  layers i n  the gradient column, thus en- 
abling a multiphase density separatio:! colum. Albumin, l i k e  Ficoll- 
Hypaque, i s  non-toxic t o  cells .  
Several combinations of albumin solution were t r ied  f o r  ttie purpose 
of determining t h e  combination nos t suitablc f o r  t u ~ o r  c e l l  separation. 
The range of concentrations af these solutions was fron 7 $ t o  27 % 
album*.. Cell viabi l i ty ,  meswed by a dye er,clr?sio3 ( ~ ~ r k s  ancf Wallace, 
l?Sa), was used t o  indicate fractions k i t h  an enricbnent of l iv ing cells. 
The purity of fractiocs was determined by sta-ining mthods. Although 
) i n i t i a l  r esu l t s  were indicative of s o m  potcnt ia l  fo:. this mthod of 
tumor c e l l  separation, the variat ion i n  purity and viability between 
tumor c e l l  sources and between fractions seened too great to  achieve a 
predictable separation pattern by centrifugation. 
An earth-based method more appropriate f a r  sepwation of tumor ce l l s  
may be lase r  activated c e l l  sorting. However no opportunity t o  t e s t  t h i s  
poss ibi l i ty  was available. The appl ica5i l i ty  of l a s e r  activated c e l l  
sort ing f o r  t u m u r  c e l l  separation i s  a lso  dependent upon the ava i lab i l i ty  
of an adequate fluorescent marker fo r  these cells .  
A very tenuous v iab i l i ty  of tumor ce l l8  upon removal from a host 
environment was observed i n  these studies. T h i s  may render them a poor 
candidate f o r  space bioprocessing separation procedures. However they 
.- 
should not be ruled out on t h i s  basis  alone since it may be possible t o  
es tabl ish  conditions t ha t  would overcome t h i s  disadvantage a s  the Shuttle 
program develops. 
b. Separation of Lymphocytes. 
Lymphocyte subgroups seem more appropriate candidates f o r  space 
biopro:essing separation. Techniques fo r  extensive c e l l  culture, re- 
quirements f o r  prolongs-d viabi l i ty ,  several assay methods, and a broad 
spectrum of clinj.zal.ly relevant research in te res t  have been established 
f o r  these c e l l  t y p e s .  
Lpphocytes are c r i t i c a l  t o  a normal h n e  response. T h e i r  ro le  
i n  the  various steps required fo r  immune fwc t ion  is  accomplished by 
several d i s t i nc t  subgroups. A t  l e a s t  five categories of lymphocytes are  
I 
now thought t o  exist.  These are  B-lymphocytes, T-lymphocytes, ef fec-  
t o r  ce l ls ,  suppressor ce l l s ,  and k i l l e r  cells .  The ava i lab i l i ty  of 
homogenous preparations of these c e l l  t p s  would be of great importance 
i n  the  study of t be i r  mechanism of action. However, an even more impor- 
t an t  advantage of t he i r  i s o l a t i o n  may ex i s t  because of the immune- 
mediator substances they may produce, The culture of pure subgroups 
may enable the earth-based recovery of these products on a commercial 
scale, Therefore a preliminary study of current methods of lymphocyte 
separation was considered very compatible Kith tbe  potential  development 
2; zz1ce S i o ~ ~ o n e a s i n q  a?rlicatic:s. 
Two density gradient centrifugation methods were evaluated f o r  the 
separation of lymphocytes. A continuous phase of Ficoll-Hypaque solu- 
t ion  was the gradient i n  one approach and a discontinuous phase of 
albumin solutions was the gradient i n  the other. The method w i t h  Ficoll- 
Hypaque i s  a cornonly used ~rocedure  fo r  separating lymphocytes from 
erbthrocytes i n  soluticns of whole blood. However no apparent advantage. 
of t h i s  method for  separating lymphocytes in to  subgroups was evident i n  
these studies. 
The use cf albumin solutions as a gradient seemed more appropriate 
fo r  preparative s s ~ a r a t i o n  of lynphocytes in to  subgroups. A sharp rie- 
l ineation of frzcticrs and an extensive ve r sa t i l i t y  were possible by 
~ t i l i z i n g  differen5 co~binat ions  of a l b u ~ i n  solutions di f fer ing i n  con- , . 
centrat ion.  Eacause a \ ~ r y  limited m b e r  of cells can be handled per 
gradient col-mni, t h i s  ~ e t h o d  i s  not v e v  suiiable fo r  large scale prep- 
arat ions of lyxphoeyte subgroups. Also the poor homogeneity observed 
i n  the fractions uas not  very suppcrtive of t h i s  rethod for  i sola t ion 
of these subgroups. 
c. Isolat ion of Ekematoid Factors. 
A macromolecular separation method based upon adsorption was used 
i n  the isolat ion of rheumatoid factors from plasma. Elevated t i t e r s  of 
rheumatoid factors are found i n  the plasma of patients aff l ic ted with 
rheumatoid a r t h r i t i s .  These rheumatoid factors  are i ~ m o g l o b u l i n s ,  
presumably of the I@ class,  and have an a f f i n i t y  fo r  I# immunoglob- 
ulins. Such a f f i n i t y  i s  ut i l ized i n  removing the  rhel;:ratoid factors 
. - .  
v , . - - r  ,;.-;<.r.-. r r ~ ~ ~ ~ ~ i ~ y , ~ - r , ~  fif ~7 yt ?*.? .:::t.,:.:i. :, . - . .. :tiis aff i n i t ? .  
releasing the rheumatoid factors. T h i s  separation procedure served a s  
an excellent example of r n o l e d a r  separation techniques involving affin- 
i ty  by weak b o d  formation. Rheumatoid factor  was considered an impcr- 
\ 
tant c a d i d a t e  fo r  separation because of the observation iri this labor- 
atory t ha t  it ray be responsible f o r  complement-dependent Wury t o  
tmr-der ived  ce l l s  but not c e l l s  from normal tissues. T h i s  was s u p  
gestive of a functionally specific subgroup of t h i s  irmrLunoelobulin class.  
Therofori plasma w i t h  high rheumatoid factor  t i t e r s  was adsorbed 
using aggregated human garmaglobulin ar,d then eluted w i t h  glycine-phos- 
phate buffer ( p ~  2.jj i~eCarvalno e t  ai., l ybb;  Torriyiani et al., 1970). 
The eluted rhuematoid factor was resuspended i n  phosphats-buffere? sal?.?;: 
(pR 7.2) and reduced by vacuum dialys is  t o  t.he volme of the or i r i a a l  
plasma (Hejmer and Schwartz, 1961). 
Semi-quantitative assays f o r  rheumatoid fac tc r  a c t i v i t y  w r e  per- 
formed on the dialysate arvl a p p r ~ x b ~ a t e l y  50 % of tt:e original  activity 
1 uas isolated i n  the dialysate. However -imuno-assays of the dialysate 
were indicative of substantial impurities. A continuous flow electro- 
phcresis separation nethod was used i n  an a t t m ? t  t o  remove these i ~ ~ p u - - -  
ities from the d i a lpa t e .  Four fractions resulted but rhewatoid factcr  
ac t iv i ty  was detected i n  only three of these. The fourth fraction,  a l -  
tbough void of rheumatoid factor  act iv i ty ,  contained 43 46 of the protein 
present i n  the original  dialysate sample tested (Griff in,  1976). T h i s  
was evidence of the need for *roved pwity of imnune-related compourcls. 
The specif ic i ty  of adsorbicg agent appeared t o  be the l imi t ing factor i n  
the adsorption separation method. A superiori ty of electrophoresis over 
~ : : s . - , r r t i  c n  mtk3ds %as also 3m;x:::t:'z?,:'3 r-.- tc: : . -ern; ,,,e. The advsn- 
tages of electrophoresis may be even greater i n  electrophoretic systems 
developed for  space bioprocessing in f l igh t  use. 
&. Identif icztion of Ground-Based Assay nethods Needed f o r  Pre- and 
Po:.tflirht Anzl:fsis of Space 2ioprocessing Technology. 
--- 
It would Ee inrpossible t o  precisely and completely identify t h e  
gro~xnd-based assay methods needed fo r  am'lytical support of space bio- 
prt,:essing a t  t h i s  ear3.y stage of i ts  development. Therefore some basic 
as?. 9 nothods with a broad s p c t m  of exist ing and potential  applica- 
tions tare studied ar.3 evaluzted fo r  t he i r  general appl icabi l i ty  t o  
spit,::e bioprocossing, These rrethods xere imniunodiffusion, cyt.otoxicity, 
a r d  cell speci;i? staining procedures. 
a, I r u x ~ o c  il"r'us;.c.n, 
-- 
1~cur.odi:"i'usion i s  a mthod w h i c h  %as developed in to  extensive ana- 
_.ytic?l capabi l i t ies  by Oucterlorz,p (1958). It is useful primarily fo r  
detrc'iinp, and r.:easuring irmune-reactive compounds. Tbe rhematoid factor 
dlalyzate was used as tho t e s t  m t e r i a l  in t h i s  e f for t .  Diffusion was 
c?-rrled out  in an agarose mcdiw. agains t  several different  innmme-reac- 
tive gloups. I t  ayp~ared t ha t  tbe  ~ ~ a j o r  protein impurity in t h i s  d ia l -  
yscrte was of thb  IgG c lass  of immunoglobulins. Imrmrnodiffusion was found 
t o  be ext- ~ m l y  sensit ive and could detect even t race  amounts of immuno- 
L. Rossette Fornation. 
-. 
Another bioassay method studied was that of rosset te  formation. 
I - , ? , :  
. ,.- . . -' .:. procl .,;rF1 ;;;;t:ci u?*cn r.c.c?c t,; c?s b ~ t u e e n  cell:- a5d irmrmnopiob- 
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ulins on ce l l  membranes, A common variation of t h i s  method is used i n  
assaying for  B- and T-lym~hocytes, Certain lymphocytes are able t o  form 
rossettes by binding with untreated cheep red blood ce l l s  or with immune- 
activated SL ,ep r e d  blood cells, The technique i a  not a3 reproducible 
as desired and individual technical s k i l l  seems a significant factor i n  
i t s  successful performance and reproducibility. 
Another significant variable i n  t h i s  assay method is the source of 
sheep red blood cells. An adequate standardization source for these 
assays i s  not yet available but psrhaps a purified ce l l  fraction obtained 
via s?ace bioprocersing c r d d  be used t o  in i t i a t e  t h i s  standardization, 
In spi te  of the variation L? t h i s  assay method, acceptsbly consistent 
resul ts  are possible i f  cart.ful technique i s  exercised and the sheep 
erythrocyte source is  kept cccstsnt. 
c. Cytctoxicity. 
Urier appropriate imme stimulation, ce l l s  can be made susceptible 
I I t o  dmage i n  the presence of fresh co~plement. In t h i s  manner, cytotox- 
i c i t y  assays nay be used to  measure the effector substance or the target 
cells,  T h i s  dual capacity r e ~ d e r s  t h i s  assay method of great potential 
Because rheumatoid factor appeared t o  be c;rtotoxic t o  tumor-derived 
cells,  it was used as an awnue to  study cytotoxicity assay techniques. 
Incubation of target cel ls  with rheumatoid factor and fresh plasma was 
conducted by prc-sicitisl y established procedures (Klein, 1971 ; Stewart 
and Goldstein, 197k). Controls were similarly treated except the plasma 
w s  h ~ s t e d  t o  i ~ a c t ! r . t e  tL,c ccr.??.cz::;?t. At, tS13 r;?lrt, ce l l  v i a b r i t p  
c.sl?ild bo rneas~rred by the T m a n  Lluz c x c i ~ s l c n  zeti;:? {Hanks ard W a l l k z ~ ,  
19%). However t h i s  method seemed semi t ive  orily t o  c e l l s  with consid- 
erable damage. A more sensit ive method was fourad t o  be protease diges- 
t ion  of damaged ce l l s  (Stewart and Goldstein, 1974). 
This cytotoxicity assay method was used t o  evaluate differences i n  
the f rac t ions  obtained from density gradient centrifugation. Thc r e s u l t s  
were not suggestive of any suitable degree of pur i ty  in  these f rac t ions  . 
but they did suggest a trend towards two d i s t i nc t  c e l l  populations. The 
development of antibodies against specif ic c e l l  t-es m i e h t  be a valuable 
adjunct to t he  application of cytotoxicity methods fo r  ce l lu la r  assay 
capabfi i t ies,  
d. Staining ~ e t h o d s .  
Another approach t o  analysing the c e l l  separations pr-l.formecl L? 
this contract e f fo r t  was t ha t  of histocbe!r.iccl s ta ic ing ~r.occCurcr,.  In 
addition t o  cornonly used Wright's Henatoxin stain fcr the iaeritir'ica- 
t i c n  of leukocytes, a recently developed kuno-peroxidasc method spe- 
c i f i c  f o r  certain sub-groups of lym~hocytrs was a l so  examined, The 
appl icabi l i ty  of t h i s  inmuno-proxidase xcethod i s  presently l k i t c d  t o  
lymphocytes containing I@ or IgE on the i r  surface but can bo expa:~ded 
as more immunoglobulin classes and subclasses a r e  isolated in sufficicni; 
quantity and quali ty f o r  the production of addit ional  stnin-ing scents 
(Taylor and Skinner, 1976; Taylor and Burns, 197&). 
The speci f ic i ty  of immuno~lobulins and t h e i r  receptors on ce l l  mem- 
brane surfaces are considered by many t o  be a p r i ~ c i p l e  functional deter- 
minant i n  effecting cell-mediated inxnune reactions (Marchalonis, 1975; 
-d ,. l..,. .. 
..,, L-?: ,.? ar: .y-:;.:.-, . : , ;.:,et,:,~ :,rz IThy, 197:; i..::.,~~ ~ , d  W i l l i ~ ~ ~ ,  
197b; Scorm, 1976; Metzgar e t  ale, 1975; Kolata, 1975; Kulczycki c t al., 
1 uno- 197h; I r i e  and Norton, 197b). Therefore fur ther  development of irr..r, 
peroxidase staining techniques may enable assay8 for  lympbocfle s ~ b -  
groups t h a t  are  highly relevant t o  t he i r  functional status.  A very dc- 
sirable feature observed i n  the use of these immuno-peroxidnse s ta ins  
was tha t  the ce l l s  containing the appropriate immunoglobulin on t hz i r  
surface were extremely evident while other c e l l s  were completely void 
of any evidence of reaction with the stain. T h i s  apparent all-or-r.or.e 
response would be very useful i n  eliminating e r ro r  r i s i ne  from su?~;,-'cc- 
t ive  in terprets t ion of c e l l  types. 
5. Efficiency of Space ~ i o ~ r o c e s s i n ~  Separation Procedures. 
In considering the efficiency of space bioprocessing ~ e p a r a t i c n  
pr~tcdurcs , attention must be given tc the s ~ p c  iod nin i l r~q  r uqui1.c. .,::I L . 
t o  effectively achieve earth-based applications of these ~rocedurc:i. 
This w i l l  include functional in tegr i ty ,  purity, and quantity. The prc::-- C, 
tha t  is recovered must sa t i s fy  the  functional requirements t o  be us;!blc. 
Therefore it is essent ia l  tha t  decreased v i ab i l i t y  or  al tered Zunctlcn 
does not occur i n  the product as a consequence of the process. Ttie rc-. 
quired purity of product may vary depending on the specific cornpourids 
involved. For example, some compounds are very antigenic and a s  im~w- 
i t i e s  may induce a disproportionate amount of immune reactive substances 
if antibodies were produced from the separated product. Requirements 
pertaining t o  quantity a l so  w i l l  vary from one separation t o  anot.her, 
Thia is pax-titularly true f o r  irmmtne-related substances. The purifica- 
t !  ..- .. C' :,;;t:~'.:; ?-: :: <;yr: : :~r . - - :g~;- r -  f'ir :: ? : , e q ~ ~ ~ . f i t .  r "'CI~iction of TT.' :- 
bodies IS representative of ttiis var ia t ion  i n  requrernent. Some an~iger,:; 
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are capable of e l l i c i t i n g  antibody production of as much as 100,000 




As a consequence of these ef for t s ,  several features related t o  
current lseparation technology, t o  problems asbociated w i t h  t h e  aepara- 
t i o n  of biologicals, t o  assay methods, and t o  determining the  efficiency 
of space bioprocessing technology became apparent. 
Separation methods based upon s ize  and mass do not seem very pro- 
mising f o r  advancements i n  the separstic;,-. of functionally specific bio- 
logicals. Centrifugation and f i l t r a t i o n  methods are among these. Thore 
d i d  not seem t o  be suff ic ient  differences i n  s ize  and mass of the bio- 
logical  e n t i t i e s  khose separation was desired t o  enable t he i r  separation 
on that  basis. Since these separation methods are not significantly 
hindered by gravity, there was no apparent advantage t o  t h e i r  use as 
primary i n f l i g h t  space bioprocessing procedures. 
Separation systems whose p r i n z i ~ l e  of action i s  selective a f f i n i t y  
binding also do not appear d i rec t ly  advantageous fo r  in f l i eh t  space 
bioprocessing procedures. The s ignif icant  limit in^ factor observed i n  
these systems was the specif ic i ty  of the binding agent. Gravity is not 
considered d i rec t ly  responsible f o r  l imiting the  utility of these sys- 
tems but indirectly it may be a factor  i n  restrict.3.n:: t h e  availeS4ilitj 
of mom specific binding agents. 
Electrophoresis u t i l i t e s  size and moss and a lso  electrochemical 
_ L '  , . . , ,  - .,,.. 7- - 
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l imited by gravity and therefore may be enhanced by operation i n  the  
near weightlessness of tbe Shutt le Spacelab. Of  the aoparation systems 
examined in t h i s  study, those based upon electrophoretic methods seemed 
most appropriate fo r  M l i g b t  space bioprocessing procedures. Also the 
qua l i ty  of separation even under ground-based res t r ic t ions ,  was found 
advantageous over other methods in purifying the t o s t  material used i n  
t h i s  study. 
The separation of biologicals presented some unique challenges t o  
separation technology. In  addition t o  being able t o  isola te  the bio- 
log ica l  ent i ty ,  a biological sepcration procedure must often be protec- 
t ive  of t h e  functional a b i l i t y  of the protl.ict. T h i s  requires very deli- 
ca t s  handling prior, during, and a f t e r  the s ~ p a r a t i o n  process. In  cases 
of c e l l  separation, the membrane surface often contains the determinants 
t h s t  render a c o l l  functionally d i s t inc t  from other c e l l s  of similar 
structurs. Electrophoresis and aff ini ty  binding systems ut i l ized t h i s  
1 surface chemistry f o r  separation and appeared most sensit ive t o  func- 
t iona l  differences i n  separating biologicals. However as stated pr5- 
vionsly, electrophoresis was the only method t ha t  appeared of potential  
advantage f o r  inflight space bioprocessinq procedures. 
A major drawback observed f o r  c e l l  electrophoresis was the absence 
of suitable standards. A purified c e l l  l i n e  of stable and extensive 
ava i lab i l i ty  would provide a means of predicting mobility f o r  space bio- 
processing sepaxtions and enabling an improved correlat ion of c e l l  assays 
between laboratories. One resu l t  of the  rosset te  formation assay pro- 
cedures was a stronq indication of the  need f o r  a stm3ardized c e l l  prep- 
a r a t i o n  f sr 1ntar labwatsr - j  crcrrzia; LC.:: sf thesh azqc-:%. 
An i n d i r e c t  re la t ionship  of o ther  separat ion systems t o  space bio- 
processing was apparent i n  t h i s  study. The binding agents used in con- 
s t ruc t ing  the  a f f i n i t y  separat ion columns could be pur i f ied  by space 
bloprocessing procedures and used f o r  eartb-based separations.  Since 
many of these agents are recoverable from the columns and t h e i r  produc- 
t i o n  nay be cultured by animal immunizetion procedures, t h e  usage derived 
from one f l i g h t  mag be q u i t e  exbns ive .  
Another separat ion problem that  may be a l l ev i a t ed  by epace biopro- 
cessing is  that  ~f uneven packing of gel f i l t r a t i o n  columns. Column 
proparation on earth does not  r e s u l t  in  an absolutely homogenous densit.:? 
d i s t r i bu t ion  of mt rh  material .  This can bo a limit in^ fgc to r  the 
qua l i t y  and ef f ic iency  of some separations.  
Of the asszy procedures studied, nona seemed co,?;plet.ely adequate t o  
meet the  po ten t i a l  requirements of space bioproccssinp;. Homver these 
assay procedures were dependent i n  varying degrees upon e x i s t i n g  earth- 
based sewration technology. As separat ion t c c h n o l o ~  is advanced by 
space bioprocessinq, t he  opportunity f o r  i ~ r o v e d  essay procedures 
should follow. Therefore these assay procedures i n  their present  state 
should be considered only a s  t e m ~ o r a r y  supporting rrlcasures f o r  space bio- 
processing technology. 
Cytotoxicity-based assays seemed t o  mos t  s e n s i t i v e  b u t  theso are a 
des t ruc t ive  form of assay. The amount of mater ia l  required f o r  cyto- 
toxic analys is  may be a arawbacir i n  s o w  cases. An apparent alternative 
was t h a t  of ce l l - spec i f i c  s t a in ing  methods as r e p r e s e n t 4  by the humno- 
peroxidase stains. Very l i t t l e  material was required since t h i s  is a 
: I ; I :  *c. t,. * '  4.0 J-?r. * *,-A .i.<.j - :  ' ri:-;.A : :,ie.. i ;>n.c/ c:' ? , - 3 ~ ~ i f  i~ a S S % Y c ;  
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seemed currently limited by a lack of the specif.  :ally reactive agents, 
T h i s  l imi ta t ion may b lessened by space bioprocessing separation pro- 
cedures as w e l l  as-further earth-based developments of these agents. 
Purity, quantity, and v iab i l i ty  were often unsatisfactory and were 
t h e  l imi t ing factors i n  the successful application of many earth-based 
separatior, techniques. Although pur i ty  and quantity may b y  improved by 
space bioprocessing, v iab i l i ty  may not, A dependence of v i ab i l i t y  on 
proper handling was observed i n  t h i s  study and nay become a maJor factor  
in t h e  l imitat ions of space bioprocessing, In  t h i s  study the  increased 
sens i t iv i ty  of the protease digestion method i n  comparison t o  dye ex- 
clusion measurement fo r  detecting minjmal c e l l  damage was very evident, 
There was no evidence t ha t  t h i s  mininral dama~e d i d  not influence c e l l  
function. Therefore the protease digestion nethod would seem the pro- 
ferred one f o r  the assessment of v iab i l i ty  under space bioprocessing 
/ 
Tumor c e l l s  exhibited an extremely poor v iab i l i ty  within a short 
time a f t e r  t h e i r  removal from the host environment. In sp i t e  of the 
potential  research value of t he i r  separation, t h i s  poor va ib i l i ty  m i g h t  
render unsuitable t he i r  separation by space bioprocessing, 
Lymphocytes seemed more comptible with space bioprocessing i n  t h i s  
respect. Tbeir v iab i l i ty  was f a r  greater and enduring. Tho amenability 
,f lymphocytes t o  wintenance throueh establi.shed culture techniques, 
the  broad range of c l i n i ca l  research in te res t  p iwn them, and the inade- 
quacy of current separation methods i n  isola t ing functional subgroups 
w011l.i a l ~ n  s ~ ? ? n ? t .  t Q ? m  as sr.anc o i  ?rr?:es:;Lris t..-r.:'.ii-~~es. 
hnanoglobulins and antigens were found t o  contain an extremely 
vast  number of worthwhile components whose isola i ion iould he of great  
significance and value t o  the biomedical community, The potential  bene- 
fits of t h i s  capabil i ty t o  therapeutics, diagnostics, and research were 
found t o  be equally Smpressive, 




Throughout the  contract period, a portion of the e f f o r t  was dirL..,il 
toward support of the a c t i v i t i e s  of t.he NASA/JSC bioprocessing off ice. 
These a c t i v i t i e s  were varied and dependent upon thc requests of t h e  bio- 
processing off ice  a t  t ha t  time, Supportine documentation f o r  Shutt le  
experiment proposals, responses t o  administrative correswor.dence, a ss i s t -  
ance i n  planning and arranging a Colloquiuin on Biopr~ccssing held i n  
March, surveys of technical l i tera t iwe,  and technical input t o  biopro- 
cessing related developnents were among these ac t iv i t i e s .  Proposals 
re la t ing t o  the separation of cytotoxic c e l l  factors,  c e l l  culture 
biosynthesis, electrophoretic behavior of plant ce l l s ,  and multiphase 
par t i t ion  separations were involvzd i n  these efforts .  Extensive sup- 
port  was also given t o  the preparation of a program plan fo r  space bio- 
processing inc ludhg  technical evaluation of objectives, mechanisms f o r  
e f f i c i en t  development and implementation of experiments, and iden t i f i -  
cation of projected hardware develo?rcent requirements, 
Experiment Proposals 
Techn ica l  suppor t  o f  t h e  B i o ~ ~ r o c e s s i n g  program a t  JSC r e s u l t e d  i n  an 
example exper iment submi t t e d  t o  t h e  L i f e  Sciences Spacelab Cl iss ion Develop- 
ment t e s t  s e r i e s  and a  formal  p r o p o s ~ l  t o  t h e  Announcement o f  O p p o r t u n i t y  
f o r  t h e  f i r s t  Si;acclaL ;;iss ion  (AO-055-76-1). 
Proposals : 1) Separa t io t l  o f  C y t o t o v i c  C e l l  F ~ c t o - s " ,  proposa l  n ~ .  92, I 
on June 19, 1976. ' I  
2) "Separa t ion  o f  C y t o t o ~ i c  C e l l  Factors ,  p roposa l  f o r  JSG 
Spacela3 fli s s i o n  ~ e v e l o p m e n i  'I'ebt; I 1  I, A;s~i;l 5, 197 i .  
9, Recomendaticcs, 
1 
I n  pursuing thsse contract a c t i v i t i e s  several  aspects related t o  
space bloproccssing becake evident. Some aspects  were strongly plausi'tlle 
and o thers  were not. Therefore it was deemed approprjate t h a t  s~me rcc- 
o rc?nda t ions  shocld bc eqresscd base:) ~ 3 3 1 ~  x h ~ t  x39 l z ~ r i l e d  dur ing  
conduct of t h i s  contract.  
a. Cell Scparstims. 
- 
Several areas of c e l l  separation were ident i f ied  as potent ia l  bcna- 
factors of space bioprocossing. Tne separation of lymphocytes suberou?~ 
would be of importance t o  the c l a r i f i c a t i o n  of immune response and re910 
l a to rg  mechan~sms. Pure preparations of B- and T-lymphocytes nught 
soroe as  primary standards f o r  associated assays. Alternatively, a pure 
preparation of sheep erythrocytes spec i f i ca l ly  react ive u i t h  B- o r  T- 
lymphncytes could be obtained Ly space bioprocessinq fcr this purpose. 
W i t h  appropriate ground support from animal geneticist8 and the  Bux,eau 
of Standards, secondary standards could be established and maintained. 
Such a standardized c e l l  preparation could a l so  be used f o r  com- 
paring electrophoretic mobllity measurements from one system t o  another. 
Ths use of a standard l i n n g  c e l l  l l n e  would be of significant benefit 
- - 
i n  establishing predictive indices of mobility of unrelated cell types 
under consideration as candidates for  space bioprocessing separation 
t.echnology. Such e prcdicti;.?~? capabi l iv j  nould f a c i l i t a t e  the optimi- 
zation of the t2paration system pr ior  t o  f l i g h t  and a l so  support advances 
i n  grcw,d-based e1e~trophoret . l~.  separation of ce l ls .  
Other potential candidates f o r  cell separation i n  space biopro- 
cessing are :ells derived from endocrine tdssues. Hormone-producing 
c e l l s  could be c-lltured .follckr',ng t he i r  i so la t i cn  and used fo r  commerc- 
ial scurces of t he i r  r e s ~ c c t i v r  products. T h i s  concept was tested i n  
tbe A~ollo-Sclxz nissicn $her. urokinaze-~roducirq recal c e l l s  were 
sepa- -:.eb anci analy7ed f o r  productive potsntial .  The results of t h i s  
experixent arc very er,couragir-;g t o  further space bioprocessing appli- 
I cations. 
b. Cell P r ~ d u c t s .  
T h e  separation arid purif icat ion of c e l l  products by electrophoresis 
within the Spacelab environment could offer several potent ia l  applica- 
t ions  of space bioproceseing. Antjbodies, antigens, and c e l l  mediators 
a re  included i n  t h i s  categorj. Antibodies produced i n  response t o  
specif ic disease agents could enat le  the deveicpment of diagnostic t e s t s  
f o r  these agents. Purified antibodies of speci f ic  a f f i n i t y  f o r  other 
biolog!cals could a l so  be used i n  ctqjunction w i t h  absorption methods of 
i:~;ar;ttion t o  arhie-JC imnrc ;ed ~,u-ir,-,r \.:t,r ti\lsi. ~ , - > t b : e s  in one pravr?.:. 
It may be even more productive i n  some cases t o  i so la te  antigens by 
space bioprocessing and use them for  earth-based production of ant i -  
bodies i n  laboratoq- an-k:.ls. Antigen pwi f i c a t i on  nay be preferred 
because some antibodies can have cross reactivi ty.  
An example of the potential  inpact of t h i s  application is  exempli- 
f ied hy tunor-related ant . ige~s .  In many cases t..xliorous ~ ~ S S U E  is thocght 
t o  release molecular e n t i t i e s  character is t ic  of the embrycnic form of 
the  parent t i s sue  when darraged by physiologic responses. These molcc- 
u l a r  fragnants can be made ant.i@nic by proper aninal immunologic tech- 
niques. The resultant  antibodies could then form the basis of i ~ ~ u n o -  
assay screening t e s t s  f o r  t h e  t issue-specific neoplasms. A tor-bination 
of such assays f o r  thc more p r e n l e n t  cancers cocld enable a reh- t ive ly  
ineqensive  an5 practical  mc?r.s of mss ccreerinr camki l i t y  fcr the  
ear ly  detection of cancer. Tie ?otent ia l  econonic v a l u ~  cf such a dia.5- 
aos t i c  benefi t  i s  i d i c a t e d  by c o n s i c e r i r , ~  the currezt  expenditure f c r  
cancer detection ~ e t ~ o d s  practiced a t  preset~t .  X n  assay system of t h i s  
type has been developed fo r  carcir.oembrycriic anti.ge;: hAnch has sore cor- 
re la t ion t o  stomach aRd upTer i n t e s t i r ~ a l  necplasnls. Ho~dever this concept 
could be greatly enhanced by improved separation capabi l i t ies .  
Regulatory factors,  such as those associated u i th  inrmne-responsive 
ce l l s  and synaptic junctions would be useful i n  purif ied form f o r  t he i r  
s t ructura l  characterization and subsequent synthesis of pharmaceutical 
analcgs. The medical - h ~ l i c a t i o n s  of this achievrrient would be signifi- 
cant t o  both research and c l i n i ca l  advances. 
c. Technolorn f o r  Bioorocessine Laboratorv a t  NASA /EC. 
As potential  applications of space bioprocessing*became apparent, 
fhe need f o r  a bioprocessing support l abo ra toq  located a t  the Johnson 
Space Center becare more evident. Freliminary hardware and analyt ica l  
requirements f o r  such a basic support laboratory c a ,  be developed from 
experience gained w i t h  relevant laborctory methods. 
The minimum hardware requirements should consist of a refrigerated 
centrifuge? l i g h t  microscope, fluorescent nicroscope, carbon dioxide 
incubator, ref r igera tor ,  freezer, weighing balance, u l t ra - f l i t r a t ion  
cel l ,  d ia lys i s  systex, s t e r i l i z e r ,  acc g e l  electrcy?boreais system. 
Additional require;nents should  be exy:ecAtec1 i n  r2sponse t o  fur ther  devel- 
opmnt of space bioprocessing applicat i  cns . A t,renirxlms advantage uo:iLd 
rcsu l t  i f  s d f i z i e n t  support uew also avail~1;'ie t o  provide a lase? 
activated c e l l  sort ing system. 
Support f c r  a broad spectr-rn of in'krests i n  spscc bioprocessing 
experiments would be possibLe i f  techniques asscciat.;d with cel?. cu l twe ,  
: 'dentificatfon of 5- and T-lynphocytes, fluorc.lscsin coiljugation assays, 
dialpsls ,  m ~ l e c i l a r  f i l t r a t i o n ,  and b n e - c c i l  spccif ic stainicg u2r.e 
availzble. The forarnentj.or\.ed h:zdware requirencnts are con~~2 t ib l e  w i t h  
these analyt ica l  capabil i t ies.  
Perhaps a suitable material f o r  use in  developing c e l l  separation 
methods within t h i s  bioprocessing bbora to ry  would bo lymphocytes do- 
rived from mouse spleens. This is a readily avsilable source and would 
be representative of maqy c e l l  separation characterist ics.  A secondary 
benefit could be forthcoxrLng early i n  the space bioprocessing pragram 
5 r +  . . <-... ..r,.., ? f  .p-,- 
, .. . , , . if' " . .. , I L  %.,,,..- cf  b-:-.r?-l~acl~-t.c.s cr-.: be obtained :?--. 
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the development of separation technology. A very sensit ive tbW.2 hor- 
mone assay valuable t o  immunologic diagnosis has been developed recently. 
However t h i s  method rcquires B-lynphocytes i n  relatively pure fractions. 
The purity of these cells is  obtaitlab'ie currently cnly Iron athS;;l'c mouse 
spleens but t h i s  requires tho trerzndous ex-pense of maint.airAng isolated 
colonies of these unique mice. A means of obtaining 8-1p.phocyte frac- 
t ions  from normal mice w o s o  obviate t h i s  expense and @ace t h i s  capa- 
b i l i t y  f o r  thynic hormone assay within the budqetary constraints  of most 
laboratories. 
d. Sewrat ion Criteria. 
Periodic reviews of separation c r i t e r i a  should  occur as separation 
carididat.es for space bioprozessing sre devc~loped. Viability, r1 quired , . 
purity and quar,*,ityt and cons iaer~t j .on  of cl!.rrezt, ad-;ar,i...:s i n  ~ ; i r t h -  
based technology should be included i n  t t c s c  reviews. w i l l  cnsure 
t h a t  separation cardidates are not fl.oxn u n n s c e s s a ~ ~ ~ r  zrL: t h a t  i h e  
j l a t e s t  relevent separation technolor.~t can t o  i?ccq:ora'ccd i n t o  s p z c  
bioprocessin.g procedures. 
The availability of the Shutt le f l i g h t  sjxirrlaticn fac i l i ty  should 
be taken advantage of a t  l e a s t  thrice p r i m  t o  f i n c l  appro.ral of trj 
hardware sgstems. The f i d e l i t y  of space bioprocessing exprLwnt simu- 
l a t ions  should be as r e a l i s t i c  as possible and encompass such areas as 
log i s t i c s ,  storage, waste disposal, power and timeline requiremnts, 
compatibility w i t h  other ewr i rnen t  requirements, exercises i n  correc- 
. . . , . r:,,,: , L:.; ntive crcunci tic.:; c: ~ r c J a b i e  riif  c n c t l a r : ~ ,  a x  srG-- - . .A- 
support. 
During the twelve ~ o n t h s  of this contract effort, experience u8s 
gained i n  the arec.s of in~:runology research, separation procedures, assay 
methods, and spaco bioproccseing requirements and was u t i l i s e d  in devel- 
oping poteritial appiicaticz;:: o f  Lrpace bioprocessing. Separation methods 
of cells and cell products vere exm-ined, zn~iu6ir.g density gradient 
ce~tr i fuqat j  A, affinity ctiroxriatography, f iltrati.cn, e l e c t r o p h c x ~ i s ,  
and lasap activated ce l l  sol.ting. Cytotoxicity analysis, rossette for- 
mation, Lmmodifiusion, vi-ability, and staining procedures were amant 
the assay mthods examir,?d. Severd potential bpplications of space bio- 
prococsing usre identific5  id rccoir&~ri2ations were made pertaining t o  
tho furtiler de-felcpxsr,t of sr;sc~ bioproczssitg, Some requirements far  
in-house sup3ort of space bioproc.?ssinr: w-3;re also identified. Based 
up33 this exy,arier;~c, s e v a a l  co!:clusions were reached t h a t  would snq- 
gcst that c ~ r r e n t  technof.ofy is not entirely sst i  sf ectorily for  support 
of space bioprocess$.ri~ kut -trill hnve to be developed further in selected 
areas concorrmittsnt~ly with space bioproccssing technology. 
This contract ef fort  w:?s a w r y  ap~ropriatr? means t o  study space 
bioprocessinz applications to  b i o v d i c a l  research areas associated with 
jnnnunology. Baaed upon this atudg, several conclusions were suggested: 
a) Current separation methods are inadequate t o  meet the future 
needs for seyaration of biologicals import.;mt to bjomdical research and 
industry, 
b) Electrcmhoresis anmared t o  be the only aebaration lasthod suit- 
c)  Separation systems based on chemical a f f i n i t y  such as adsorp- 
ta lon chrcmatography may be improved indirectly through space bioproces- 
c in :  by a greater avai labi l i ty  and pur i ty  of binding agents. 
d) Gel f i l t r a t i o n  methods may benefi t  indirect ly  from space bio- 
~.i-ocessil-i,- thrcugh improved honlogeneity i n  column packing. 
e )  Sa",isfactory assay systems were not apparent f o r  functionally 
s ~ z c i f i c  c e l l s  and c e l l  products t o  the degree of refinement potential ly 
r:(~~'Jired f o r  analytical  s u ~ o r t  of space bioprocessing. 
f )  A lack of acceptable standards i n  many cel lular  assay systems 
;;:s sug~estr:d and w i l l  have t o  bo developed before or  conconnittantly 
..;.! :,.,LC. zptcc. bioprocessing separation techniques f o r  a meaningful anal- 
.-, 
., ..I: of the  result;. 
g) Cel l  ~ r e p ~ 8 t i c n s  with standardFzed elecfrophoretic mobility 
7-c x.e:';?d f o r  both space bioprocessing and earth-based systems. 
II j L~iphocyte  subgroups, tumor-related antigens, and immune f unc- 
5 0 3  ~r;sGisrtors seem the more pronising candidates i n i t i a l l y  fo r  apace 
. . I:~moprccessing separations. 
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ABSTRACT In this survey for rheumatoid factor (RF) 
rempositivity on patients with neoplasms, an 85% rate of pos- 
itive screening tests was recorded under certain circumstances. 
This high rate of RF sero ositivity occurred after irradiaticn 
and/or chemotherapy of ireast and lung cancers. Treated pa- 
tients with breast cancers who had no evidence of residual 
tumor had an 89% rate of positive RF tests. Conversely, the in- 
cidence of RF seropositivity was low among untreated patients 
with similar tumon and treated patients with glioblastomas or 
multiple myeloma. The administration of cytotoxic d n ~ p  (e.~., 
u t h i p r e n e )  was not itself associated with RF production even 
in renal allograft recipients. Thc data indicate that R F  pro- 
duction occurs frequently after therapy of certain tumors and 
suggest that in these circumstances RF may be an expression 
of tumor-host interaction. 
Rheumatoid factor (RF) is detected by routine latmratory 
techniques in serum from 5 4 %  of healthy adults under 65 years 
of age ( 1 3 ) .  About 13-20s of unselacted patients with 
malignancies are R F  seropositive (1, -I, 5) .  and RF has been 
eluted from ~ieoplastic but not from adhcent nornlal tissut.s (3. 
The relevance of this antibody response to tumor-host intt-r- 
actions is not known, nor are  circumstanccs that cause it to 
occur. 
Mort RFs are IgM antibodies to antigenic determinants in 
IgC. In general. Ig5l is a more effective activator of complc- 
ment than IgC (6,;). However, the effect of Igkl-RF on com- 
plement mediated reactions is variable (6-1 1). For exa~nple, 
IgM-RF induces complement-mediated neutralization of 
herpes simplex virus complexed to IgG antibody (9). However. 
RF may inhihit complement-mediated phagocytosis (10) and 
lysis (11) of erythrocytes sensitized with Ifi antibody. The basis 
for this difference in the interactions of con~plrrnent, RF, and 
antibodies of the IgG class is not known. 
This report presents evidence that RF is readily rletectc.d ill 
serum from many patients with solid tumors and that conven- 
tionaltherapy of these tumon contributes to the occurrence of 
this antibody response. 
PATIENTS AND METHODS 
All subjects included in this study were under 66 years of age. 
The diagnosi. was confirmed microscopically in all cases of 
malignant disease. The fr~llowing suhjc~ts were included in the 
serologic survey for RF: (a 156 .patients with breast cancer. ( h  
42 patients with quamolls cell carcinoma of the lune. ( c )  91 
patients with multiple myeloma. (d) IP patients witir glio- 
blastomas, (e) 21 patients without known malignancy receiving 
cytotoxic drugs for the purpose of immunosuppression, and Cf) 
21 healthv \o!ttnt~-r\ Thirt* -cc-vr!7 r!f !hc >.!rir.nt with l ~ r    st 
. , 
caprvbr and .1 i1  1: :*,,!;d,:~ik \v~t!! 1111): .&I: ,  *-r IS.I !I  I : I I ~ I W ~ I , ! , ~ ~ I I P -  
and u ~ d e l v  r n ~ . t . ~ > t , i : . ~ ~ t ~ ~  i8 t f tp~ . ib~~i \  .i-rt*.~t~i~t*r~! I I I I , I I I C ~ ~ - I I  l r l i i -  
Abbreviations: I& ~mmunoglobulin: RF, rheumatoid factor. 
' Reprint rquuts  to J .  J .  Twnmev. M 9.. V. A. Hospital, 2001 Hol- 
cornbe elvd.. Hooston. Texas 7721 1 
diation (3500-4500 R or 35-45 J/kg) from a cobalt source and 
adminiztr:~tiot~ of various chemotherapeutic agents intrave- 
~iously i r ~  tlosr schedules dictated by patient weight, clinical 
status, nnd  drug tolerance. These drugs included cyclophm- 
phamide, vi~iblastin, methotrexate. 5-fluorouracil, thieTEPA. 
r.nd strroids. Multiple myeloma was treated with irradiation. 
melpha!:ui, and, in sclected cases, steroids. Glioblastomas were 
treated ui th  irradiation to the head and with steroids. Most 
patients hod r i ~ c i v ~ l  cnurrs  d ttierapy before their 
scBnlm was tested. Nineteen pt ients  with breast cancer had no 
apparcst~t residual tutnor after radical mastectomy and had 
rcceiv.t*ct "pr opl~vlactic" irradiation and chemotherapy before 
they \rrcrc tested. 01 ttrc patirrits receiving cytotoxic drugs, 
which \\.crtA administc.rt>d for immunasuppression. 11 were 
rrrrrl :tllojraft recipients and 10 had multiple sclerosis. The 
renal a!lng;aft recipients were receiving 100-175 mg of ata- 
tl~ioprc~rt- R I I ~  up to 80 mg of prednisone daily; patients with 
rnultipl(3 ~c,leio~is webre receiving azathioprene at 50 mgjday. 
Sera t r  t.1.:. trcte!! for i\F at 1 2 0  dilutions with glycine-saline 
I~ufft*: ~i..ing !:rtc\ !~;crticles coated with Colins Fraction 11 
. ( I  1yla1.d L:~l,oratori~s). 
RESULTS 
'1'11~. resril!~ of the sercilogic survey for RE are listed in Table 1. 
Twent) c ~ f  t t ~ e  2J pitients with breast cancer and I5 of the 21 
patielits tvith irlrig cancer \vho had extensive tumor involvement 
and had prior irradiation and/or chemotherapy were R F  
scropositivr. Thr  fi:;d,ttgs did not appear to  be influenced by 
the typv c,r tluratior~ of treatment. Despite the absence of cle- 
tcctallta rt qidual t~~rnor .  17of the 19 treated patients with re- 
sected ltrcxst canccsr \vcre also seropositive. These rates were 
significai~tl: higher ti1311 thow rcwrded on the 21 healthy 
su1)jt~cts. none of wllrbnr was seropositive ( P <  0.001 by chi 
square trsls). In contrast to the treated patients, only one out 
of 15 paiivnts with mrtastatic breast cancer and twoout of 21 
patirnts wit11 n~etastatic lung cancer, who werc tested prior to 
therapy, \\-ere seropnsitive; these values were not significantly 
different from our control exwrience. Onlv one out of 21 ba- 
r 
ticnts with treated multiple myeloma m d  none of 12 p t ien t s  
with trcatetl gliohlasttln~as was seropositive. Likru*ise. RF was 
not dctrcted in *rum from any of 11 renal allograft recipients 
or IO paiirnts with multiple sclerosis wlm had received cytotoxic i 
d n ~ g s  Itlr the purposc oi i~nmunost~ppresion. Serum from each 3 
of I f  trc!:~it.cl patients with metastatic tumors was tested for RF 
titer on tllrer or more occasions over a period of at least two 
months Titers of RE flectuated, and at times patients were 
it.rorlc.C.lciv+. ( . I I . I I IC~*~ I I I  Iit: t~ t r r sd id  not correlate w~tl :  d g  
l , re . r~~;~l ) ic .  c i~.inc~.s 111 t ~ ~ r i ~ ~ , ~  liass o r  in clinical status 
DISCUSSION 
r\ routine screening tcsl demonstrated the presence of RF in 3 
serum from 65% of p t i e n b  studied with breast or lung cancer : 3: 
Y 1 -."A- . -" .,--- - - . - -. . 
1 lntnrunalogy: Twomey et d. PTCC. N d .  A d .  Sd. USA 73 (lg76) 2107 
Table 1. Serologic survey for RF 
-. 
- -- 
Subjects RF seropositive Age in yearn Irradiation and/or 
i Diagnosis (mcaun + SD) chemotherapy tertcd subjects ? 
- .- -- L 
.\I~'~;~st;ttic breust carcinoma 46 t 9 Yes 21 20 I 131 I-:ISI carcinoma, n o  evidence 
19 17 j ,,I' rc*?i~duaI tumor 45 t 11 Yes 
.\]etastatic breast carcinoma 52 r 10 No 16 1 
S~~u:imous cell carcinoma of 
-- 21 15 the lung 55 t f Yea 
Squamous ccll carcinoma of : 
the lung 55 t 8 No 21 . 2  I . 
56 .- 6 Yes 21 1 , ,r llultiple myeloma 
0 (ilioblastoma 56 2 7 Yes ' 12 
k n a l  allograft recipients 26 t 9 Yes 11 0 !. 
hlultiple sclerosis 29 t 8 Yes 10 0 
Healthy subjects 49 t 12 NO 2 1 0 f, 
who had received prior irradiation and/or chemotherapy. This 
ren~arkably high rate of RF seropositivity with cancer reflected 
patient s c k i o n  (1.4.5). Therapy contributed to the occurrence 
of this humoral immune response; the prevalence of seroposi- 
tibity was not i n c r e a d  among other patients with similar 
ncr)plasrns who had not been treated. Yet the production of RF 
cnnnot be a s c r i l d  directly to the use of cytotoxic drugs since 
patients without known neoplasnis treated with these tliera- 
pelltic agents were seronegative. The prernce of RF in serum 
from 89% of treated patients \vi:hout evidence of residual breast 
callcer is of particular interest arid could be related to residual 
foci of tumor or retained tumor antigen(s). tiowcver. the 
comhirlation of alloantigens arld cytotoxic drug therap! in renal 
tr:c~isplant recipients was not associated with HF production in 
tills study. Furtflermore, a I~igli coincidence of RF and tl~erapy 
tsus riot observd  with all types of neoplasms, as exemplified 
I~erein by glioblastoma and multiple myeloma 
Tllr basis for the high frrquency of circulating RF with 
cusrtain neoplasms after irradiation and,'or chemotherapy is not 
urldt.rstood. Sucli therapy is likely to increase the amount of 
antigrnic d, terial released from tumor tissue. An immune 
rthqwllse, which may include IgC, is likely to take place if 
111rnor-related antigens reached competent lymphoid tissues 
11 has h e n  ~mstul~tecl that antigen-antibodv mtnplexes. which 
I I ~ : I ~  be related to immune responses to tumors, circrllate in 
l);itirntc and animals with malignancies (15-1.5). When com- 
~)ic~x~,d with antigen. IgC is probably conformationally altered. 
\\llich would increase the immunqenicity of IgG and favor 
111.' production (16,17). Thus, sequestration of tumor antigens 
by an ihtact blood-drain barrier (18) could explain the negative 
tc.\ts for RF on treated patients with glioblastomas. tlumorr, 
~ n i m t ~ r ~ i t y  is often impaired with multiple myelonla (!!I). 
Yerllaps patients with multiple myeloma do not have the ca- 
pacity for an RF response. 
The frequent occurrence of RF seropositivity with certain 
c l , ~ l ~ ~ r ~ o n l y  occurring neoplasms in asswiltion with their ther- 
.'I)). h35 potential impr tancr  to  tumor-host interactiorrs. We 
11.lrl. pr~liminar). evidence tlrat RF from the plirsnia of patients 
u ~ t l l  rheumatoid arthritis may be toxic in the presence of 
~1l:nplernent o cells freed from some neoplasms. 
T l ~ r  relevance of RF to tumor-host interaction is presently 
L 
,( 11 T I I I I I ~ ~ ~  ~ I \ \ I I V  ~ ~ O I I I  I{ I: v . r~ tp t \ t t I \~~  ~ : I I I ~ * I ~ I ,  hllt)wt-(i 
. 
.,, ,ttar f1t*grtst. t d  rtta(,ro\1\ t han 1i1(1 t11111or I I \ + I I I -  t ro111 11ti11.r 
a , * rt 1 1 4 1  u*-rt. u . r , ,~~ t .~ . l l~ \ f*  I I I  1 1 1 ~  r r t ~ u ~ r ~ l  , I I A J ~  SII IC~,  
Icft-fiF IS u macromolecular substance. it is unlikely that Rt: 
rr1rrw.d into the circulation could cas~lp reach tumor tisuc 
acrcns the walls of blood vessels wit11 a rmrn~al degree of per- 
meability. Thus, if RF does have potential for damagi~lg tumor 
cells, its effect in vfoo is likely to be most apparent within the 
circulation. In that case, RF may reduce the risk of establishing 
blood-borne metastases. However, it should be pointed out that 
the incidence of malignant disease is not reduced among pn- 
tients with rheumatoid arthritis, who usually maintain high 
circulating titers of RF. 
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I Research Accompl ishments 
! Tumor t i s s u e  i s  comprised of  malignant c e l l s ,  invading immune r e a c t i v e  
. . 
- .  
i c e l l s  and strornal  cells. The tumor c e l l s  a r e  t h e  s p e c i f i c  t a r g e t  of i n t e r e s t  i n  
1 i m u n o l d g i c  s t u d i e s  on tumor-host i n t e r a c t i o n .  I n  o t h e r  words, i n t e r p r e t a b l e  
. d a t a  must r e l a t e  s p e c i f i c a l l y  t o  i n j u r y  caused t o  malfgnant c e l l s  as opposcd to 
j 
( t h e  o t h e r  c e l l  types .  
The t h r u s t  of t h i s  work p e r t a i n s  L O  s t u d i e s  i n t o  t h e  p o t e n t i a l  of rheumatoid 
f a c t o r  (RF) p o s i t i v e  blood being involved i n  a humoral c y t o t o x i c i t y  system t o  
cancer  c e l l s .  The impetus f o r  t h i s  i n t e r e s t  r e l a t e s  t o  o u r  obse rva t ion  t h a t  about 
85% of p a t i e n t s  wi th  cancer  whr nave rece ived  convent ional  chemotherapy o r  i r -  
r a d i a t i o n  the rapy  conver t  t o  RF s e r o p o s i t i v i t y  (Twomsy, J.J., e t  a l . ,  Proc. Mat. 
Acad. Sci .  USA 73:21Ch-2108, 1976). It is  necessary  t h a t  such s t u d i e s  be i n i t i a t e d  
i n  v l t r o .  It was a l s o  our  f e e l i n g  t h a t  any c y t o t o x i c  e f f e c t  t h a t  ~ e t t a i n d d  t o  
KF involvcd complement f i x a t i o n .  
The f i r s t  n ine  months of t h e  funding per iod was devoted t o  e f f o r t s  i n  c e l l  
sc!paration i n  an  a t tempt  t o  s e p a r a t e  v i a b l e  tumor c e l l s  from s t romal  and imnune 
reac t ive  cell; f reed  from f r c s h  human tumor t i s s u e .  A number of maneuvers t h a t  
involvcd d e n s i t y  g rad ien t  sedimenta t ion o v e r  graded c c n c e n t r a t i o n s  of albumin 
were at tempted as tumor m a t e r i a l  became a v a i l a b l e  f o r  s t u d y  from v a r i o u s  o p e r a t i n g  
rooms. These e f f o r t s  proved unrewarding. Th i s  p i c p o i ~ ~ t s  h e  need f o r  t h e  develop- 
ment of new approaches t o  upgrade c e l l  process ing.  Th i s ,  from a n  immunobiologic 
fram* of r e fe rence .  should be we l l - su i t ed  f o r  t h e  a t t e n t i o n  o f  t h e  aerospace  
b ioprocess in r  r e sea rch  program. . 
Drtring t h e  l a t t e r  p a r t  of funding,  our  e f f o r t s  s h i f t e d  t o  a d i f f e r e n t  approach. 1 
I ,- " APPENDIX 2 (Cont . ) 
tumors were t h e  sub jec t  of these  s t u d i e s .  Malignant melanoma was s e l e c t e d  ! 
I I 
because t h e  n e o p l a s t i c  c e t l s  con ta in  brown pigment, which rCad i ly  d i s t i n g u i s h e s  i i 
i them from o t h e r  c e l l s  f reed from tumor t i s s u e .  Two sources  of human malignant 
I i 
!. I 
- ,  
; melanoma were used: (a)  1n:plants of human tumors grown i n  athymic nude mice and 
i 
. . 
! (b) when fewer c e l l s  were required f o r  experiments,  melanoma cells were der ived f 
from long-term t i s s u e  c u l t u r e s .  
men human melanoma c e l l s  were incubated wi th  RF p o s i t i v e  plasma from 
p a t i e n t s  wi th  rheumatoid a r t h r i t i s  o r  from p a t e i n t s  wi th  t r e a t e d  cancer ,  a  
complement-dependent, cy to tox ic  e f f e c t  w a s  no t  observed. . S i m i l a r l y ,  a c y t o t o x i c  
e f f e c t  was not  observed when incuba t ions  included normal plasma. However, when 
melanoma c e l l s  were i ncuba t ed  f s r  90 minutes wi th  both  rheumatoid and normal 
plasmas, a  complement-depcndcnt, cy to tox ic  e f f e c t  was observed (Table 1).  It 
> .  
can be seen from ths  data tiist a  s i g n i f i c a n t  percentage of t h e  tumor c e l l s  were 
in ju red  i n  these  incubat ions .  Cyto tox ic i ty  was observed when RF plasma was der ived 
e i t h e r  from p a t i t n t s  wi th  rileuxatoid a r t h r i t i s  or from p a t i e n t s  wi th  t r e a t e d  cancer .  5 
The cytotoxic  e f f e c t  was lo s t  when RF was adsorbed wi th  glutara ldehyde c ross -  
l inked human gamaglcbulin from the  t e s t  plasmas. 
Plasmas Tested f o r  C y t o t o x i c i t y  
C e l l  RF P o s i t i v e  Tumor 
Number S9urce Norma 1 RA Cancer 
(% Tumor c e l l s  i n j u r e d )  
1 MI* 
2 MI 





7 -  
*Mouse implant 
. .  . 
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1 Experi~ients  were done using a s i n g l e  source of melanoma cel ls  and t h e  
! / same normal liuman plasma co l lec t ion .  Cytotoxici ty  with s i x  Y i f f e r en t  rheumatoid 
a r t h r i t i s  plasms with high RF t i t e r  was t e s t ed .  It can be seen from Table 2 i 
-? 1 i 
i t h a t  not a l l  RF pos i t i ve  plasmas supported a comparable l e v e l  of tumor cell 
t ; 
cyto toxic i ty .  One plasma l o s t  i ts cy to toxic  a c t i v i t y  a f t e r  s i x  months of 
s to rage  a t  - 7 0 ' ~  (G3j. It should be noted t h a t  t h i s  l o s s  of cy to tox ic i t y  





W T i t e r  Ce l l s  In jured  
S t u d i e s  \..>re p e r f o q e d  using s e r i a l  d i l u t i o n s  of rheumatoid a r t h r i t i s  
plasma with 2 i : d i l u t e d  normal plasrna and a  s i n g l e  preparat ion of melanoma c e l l s .  
~onvel -sc ly ,  s imi l a r  s t ud i e s  were performed using s e r i a l  d i l u t i o n s  of normal 
p l a s m  w i t 1 1  ~ii :diulted rheumatoid plasma and the  same preparat ion of  tumor c e l l s .  
It can be secn  from the Figure t h a t  cy to tox i c i t y  was gradually l o s t  with increas ing  
d i lu t i ons  of rheumatoid plasma. However, the  cy to toxic  cont r ibu t ion  of the  normal 
plasma was mostly d i ss ipa ted  by a s  l i t t l e  a s  a  1:2 d i lu t i on .  
Our studi-es i nd i ca t e  t h a t  kF p o s i t i v e  plasma cont r ibu tes  t o  tumor cel l  
in jury  in  a complex, conplement-dependent humoral immune system. This  involves  
a subs ta~lce  p resen t  i n  r e l a t i v e l y  high t i t e r  i n  RF pos i t i ve  plasma from e i t h e r  
t 
'r. i 
rheumatoid o r  cancer p a t i e n t s ,  plus  a second substance present  a t  much lower t i t e r  
Z J , f., r 
: 1 3 , . ..; .; . -1 :.. ; s ix i l a r  humoral cytotcsicit : . .  :;:-=rL,n may be operati..c 3 
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chemotherapy o r  i r r a d i a t i o n  the rapy  which induces  an  RF .response. I f  indeed t h i s  
proves t o  be t h e  case ,  t h i s  immune system is dese rv ing  o f  much a t t e n t i o n  s i n c e ,  
through i ts d i r e c t  a p p l i c a t i o n ,  i t  may prove u l t i m a t e l y  p o s s i b l e  f o r  p a t i e n t s  t o  
d e r i v e  b e n e f i t  from same wi thout  p r i o r  c y t o t o x i c  o r  immunosuppressive exposur? 
t o  c y t o t o x i c  therapy.  
A cons ide rab le  volume of a d d i t i o n a l  r e s e a r c h  h a s  s u b s t a n t i a t e d  and extended t h e  
s t u d i e s  l i s t e d  above. These s t u d i e s  have been conducted i n  our  l a b o r a t o r y  s i n c e  
t h i s  c o n t r a c t  was terminated.  We i n t e n d  t o  pursue t h e s e  s t u d i e s  f u r t h e r .  It is 
4 
our  b e l i e f  t h a t  t h e  aerospace  program could make considerable c o n t r i b u t i o n  tq t h i s  
a r e a  af resea rch .  May I suggest  two a r e a s  f o r  thought: (1) The s e p a r a t i o n  of 
tcrmot frnn orher f - tpcs  of re119 freed from fresh tumor tisstte and,  the rehv ,  c - ~ r e n d  
Ir 
ti!e t-:p . : .' ,. -:. : t ~r,. ~ r . ~ . . q , ? i , : . .  : o r  :i-.ii , ir ~ t l ~ ( : i l % \ .  2 )  The separati i .7 $54 
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i I 
n j 4 
of  substances present i n  rheumatoid and normal plasma that ;ontribute t o  1 
the observed phenomenon so  that they can be characterized biochemically, studied 
a I 
. i functionally,  and perhaps, l a t er  applied t o  c l i n i c a l  medicine i n  our quest I 
for  an answer to the cancer problem. 
